Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Netto

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
The American Journal of Surgical Pathology|March 3, 2026
Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional StudyManju Aron, Darshan S Chandrashekar, Eman Adulfatah, et al.
Clinical Transplantation|November 15, 2006
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation--a clinical and histological examinationAdrian P Martin, Robert M Goldstein, Jane Dempster, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
Journal of Translational Medicine|October 23, 2014
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladderBrian K McNeil, Maximiliano Sorbellini, Robert L Grubb, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
Molecular Cancer Research : MCR|October 14, 2017
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer ProgressionBalabhadrapatruni V S K Chakravarthi, Darshan S Chandrashekar, Sumit Agarwal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 12, 2016
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladderMorgan Cowan, Simeon Springer, Doreen Nguyen, et al.
The Journal of Molecular Diagnostics : JMD|March 26, 2017
Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher AssayAlba Torres, Mohammed Alshalalfa, Scott A Tomlins, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
The American Journal of Surgical Pathology|March 3, 2026
Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional StudyManju Aron, Darshan S Chandrashekar, Eman Adulfatah, et al.
Clinical Transplantation|November 15, 2006
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation--a clinical and histological examinationAdrian P Martin, Robert M Goldstein, Jane Dempster, et al.
European Urology|August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract TumorsGeorge J Netto, Mahul B Amin, Daniel M Berney, et al.
Journal of Translational Medicine|October 23, 2014
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladderBrian K McNeil, Maximiliano Sorbellini, Robert L Grubb, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
European Urology|July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular TumoursHolger Moch, Mahul B Amin, Daniel M Berney, et al.
Molecular Cancer Research : MCR|October 14, 2017
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer ProgressionBalabhadrapatruni V S K Chakravarthi, Darshan S Chandrashekar, Sumit Agarwal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 12, 2016
High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladderMorgan Cowan, Simeon Springer, Doreen Nguyen, et al.
The Journal of Molecular Diagnostics : JMD|March 26, 2017
Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher AssayAlba Torres, Mohammed Alshalalfa, Scott A Tomlins, et al.
European Urology|October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization ClassificationGeorge J Netto, Mahul B Amin, Eva M Compérat, et al.
Pageof 32